Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Two University of Rochester technologies have made significant strides toward the market. PharmAdva, a medical device manufacturer, is poised to enter the consumer market next year, and Raland Therapeutics is a finalist for the nation’s largest business ideas competition.
10/22/2014 | 0 comments
A partnership between the University of Rochester and Xerox has created a new technology that can perceive subtle changes in skin color on the face and determine whether or not a person is experiencing atrial fibrillation, a treatable but potentially dangerous heart condition.
9/2/2014 | 0 comments
A new grant will allow UR researchers to focus on the basic mechanisms that apply to a broad spectrum of genetic and acquired heart rhythm disorders.
8/13/2014 | 0 comments
Researchers believe that a drug for a group of rare, inherited heart rhythm disorders called Long QT syndromes could also help patients with much more common cardiac arrhythmias.
5/20/2014 | 0 comments
A recent study reported in the Journal of the American College of Cardiology demonstrates a novel approach to curb heart failure that targets both the heart and the adrenal gland. The authors found that a drug compound called gallein blocks a molecular pathway responsible for the development of the disease. The pathway is present in the heart and the adrenal gland and stifling its activity in both places led to a healthier heart in a mouse model of heart failure.
5/12/2014 | 0 comments